BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Policy

  Will China’s Anti-Capitalist Hardline Take on Biopharma? Not Likely, Experts Say

  In the past few weeks, China reminded the world that it is, first and foremost, a Communist nation. The recent crackdowns on the high-tech and education industries make some wonder what other changes will be next.

  August 17, 2021

   · 

  4 min read

   · 

  Gail Dutton
• 

  Policy

  What’s Next for COVID-19? All Signs Point to Boosters

  As COVID-19 surges to earlier pandemic levels in the U.S., federal health officials are expected to authorize a third booster shot eight months after receiving the second of the Moderna and Pfizer-BioNTech vaccines, and probably the Johnson & Johnson vaccine as well.

  August 17, 2021

   · 

  5 min read

   · 

  Mark Terry
• 

  Drug Development

  Moderna to Launch Clinical Trials for mRNA-Based HIV Vaccine

  Moderna is expected to launch a human clinical trial as early as this week for an mRNA-based vaccine against HIV and indicated that it is looking for 56 people ages 18 to 50 who are HIV-negative.

  August 17, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Genetown

  Bain Life Sciences Raises $1.9 Billion to Help Fund Promising Underdogs

  The goal was to find and finance promising endeavors, including clinical trials that need a financial push, companies looking to expand globally, and firms that have experienced drops recently.

  August 17, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Business

  Hope in the Wake of Recent Failures in Huntington’s Disease

  While treatments exist to manage the symptoms of the disease, nothing has proven to be curative – yet. Several biopharma companies are working hard to change that.

  August 17, 2021

   · 

  7 min read

   · 

  Heather McKenzie
• 

  Business

  Eli Lilly Splits and Delegates Bio-Medicines Unit to Increase Focus

  Eli Lilly is undertaking a strategic transformation that will result in the formation of new business units.

  August 17, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Deals

  Eight Months After First FDA Approval, Aurinia Picks Up Two More Candidates

  The Canadian biotech announced the acquisition of two new pipeline assets that align with its focus on autoimmune and kidney-related disease.

  August 17, 2021

   · 

  2 min read

   · 

  Kate Goodwin
• 

  Drug Development

  Athira Looks to Advance Alzheimer’s, Parkinson’s Disease Research Amid CEO Debacle

  Two months after Athira placed its CEO Leen Kawas, on temporary leave, the company has appointed new execs to its team. It is also rigorously advancing its Alzheimer’s program.

  August 17, 2021

   · 

  3 min read

   · 

  Brandon May
• 

  Business

  Former Medivation Exec Charged with Insider Trading Ahead of 2016 Pfizer Acquisition

  The latest biopharma insider trading scandal stems from Pfizer’s acquisition of Medivation in 2016.

  August 17, 2021

   · 

  2 min read

   · 

  Ellen Bombela
• 

  Genetown

  Diagnostic Face Mask Detects SARS-CoV-2 Quickly, with PCR-Like Accuracy

  The prototype offers PCR-like precision without a power-source, and is stable at room temperature for many months.

  August 17, 2021

   · 

  4 min read

   · 

  Gail Dutton